Bill
Australian Organ and Tissue Donation and Transplantation Authority Amendment (Governance and Other Measures) Bill 2021
passed, as at 2021-09-02. Health portfolio.
- Sponsor
- Not recorded
- Portfolio
- Health
Recorded stages
- introduced — 2021-06-16
- second reading — 2021-06-16
- second reading — 2021-08-11
- second reading — 2021-08-11
- third reading — 2021-08-11
- introduced — 2021-08-12
- second reading — 2021-08-12
- second reading — 2021-08-26
- second reading — 2021-08-26
- third reading — 2021-08-26
- passed — 2021-08-26
- royal assent — 2021-09-02
Divisions
No divisions recorded. Most questions are decided on the voices; this does not establish that a bill was unopposed.
Plain-language summary
Written by a model from the explanatory memorandum; not the record, as at 2021-06-16.
This bill would shift financial accountability for the Organ and Tissue Authority from its board to its chief executive.
It would replace the existing board with an advisory body that counsels the chief executive on donation and transplantation issues.
The advisory board would have a chair, a deputy chair and three to five members, with skills drawn from fields such as health leadership and community engagement.
- The chief executive becomes the accountable authority under the Public Governance, Performance and Accountability Act 2013.
- The current board is abolished and replaced by an advisory board.
- The advisory board's role is to give advice, expertise and mentorship to the chief executive.
The Organ and Tissue Authority, its chief executive and the advisory board members are affected.
Sources
em
billhome
frl act